UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 377

Sortiert nach

Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy "REGATТA" results)

Terapevtic̆eskii arhiv, 2020-10, Vol.92 (9), p.30

2020

Volltextzugriff (PDF)

Resumption of anticoagulant therapy after major bleeding and recurrence of hemorrhagic complications in patients with atrial fibrillation with a high risk of stroke and thromboembolism (based on the results of 20 years of observation)

Terapevtic̆eskii arhiv, 2020-10, Vol.92 (9), p.15

2020

Volltextzugriff (PDF)

Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions

Terapevtic̆eskii arhiv, 2018-09, Vol.90 (9), p.92

2018

Volltextzugriff (PDF)

Chronic Kidney Disease is a Predictor of Recurrent Bleeding in Patients With Atrial Fibrillation After Resuming Anticoagulant Therapy (based on REGistry of Long-term AnTithrombotic TherApy (REGATA-2)

Kardiologiia, 2023-11, Vol.63 (10), p.55-62

2023

Volltextzugriff (PDF)

New Possibilities in the Treatment of Patients With Stable Manifestations of Atherothrombosis

Kardiologiia, 2017-12, Vol.57 (12), p.82-89

Panchenko, E P

2017

Volltextzugriff (PDF)

To Whom Among Patients Survivors an Acute Coronary Syndrome, Can be Strengthened Two-antiplatelet Therapy With Oral Anticoagulants?

Kardiologiia, 2016-10, Vol.56 (10), p.90

Panchenko, E P

2016

Volltextzugriff (PDF)

Value of comparative studies of “real clinical practice” in modern cardiology. Position paper based on the expert council discussion dated 12/18/2020

Kardiologiia, 2021-05, Vol.61 (5), p.79-81

2021

Volltextzugriff (PDF)

Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (6), p.59

2011

Volltextzugriff (PDF)

Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay

Biochemistry (Moscow), 2016-05, Vol.81 (5), p.439-444

2016

Volltextzugriff (PDF)

Recommendations of the Society of Specialists in Urgent Cardiology Diagnosis and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. Part 1

Kardiologiia, 2017-08, Vol.57 (8), p.80-100

2017

Volltextzugriff (PDF)

Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts’ Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association

Kardiologiia, 2020-06, Vol.60 (6), p.4-14

2020

Volltextzugriff (PDF)

Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up

Terapevtic̆eskii arhiv, 2017, Vol.89 (9), p.78

2017

Volltextzugriff (PDF)

Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (8), p.33

2011

Volltextzugriff (PDF)

Results of three year observation of outpatients with clinical manifestations of atherothrombosis (analysis of Russian population of REACH registry)

Kardiologiia, 2009, Vol.49 (10), p.9

Panchenko, E P

2009

Volltextzugriff (PDF)

Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (12), p.43

2011

Volltextzugriff (PDF)

Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions

Kardiologiia, 2011, Vol.51 (11), p.83

Panchenko, E P

2011

Volltextzugriff (PDF)

Anticoagulant therapy in cardiology: yesterday, today, tomorrow

Kardiologiia, 2010, Vol.50 (7), p.4

Panchenko, E P

2010

Volltextzugriff (PDF)

Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment

Terapevtic̆eskii arhiv, 2009-01, Vol.81 (9), p.57

2009

Volltextzugriff (PDF)

Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis

Terapevtic̆eskii arhiv, 2008-01, Vol.80 (7), p.50

2008

Volltextzugriff (PDF)

Pharmacogenetics of clopidogrel and its clinical significance

Kardiologiia, 2012, Vol.52 (9), p.44

2012

Volltextzugriff (PDF)

New Possibilities in the Treatment of Patients With Stable Manifestations of Atherothrombosis

Kardiologiia, 2017, Vol.17 (12), p.82-89

Panchenko, E. P.

2017

Volltextzugriff (PDF)

HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy

Kardiologiia, 2015-01, Vol.55 (9), p.50

2015

Volltextzugriff (PDF)

Characteristics and outcomes of atherothrombosis in ambulatory patients in Russian Federation (according to materials of international register REACH)

Kardiologiia, 2008, Vol.48 (2), p.17

2008

Volltextzugriff (PDF)

High plasma D-dimer and von Willebrand factor levels are associated with risk of upper gastrointestinal bleeding in patients with chronic coronary syndromes receiving long-term antiplatelet therapy

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Resumption of anticoagulant therapy after major bleeding and the risk of negative events in patients with atrial fibrillation (based on REGistry of Long-term AnTithrombotic TherApy-2 - REGATA)

Terapevtic̆eskii arhiv, 2023-01, Vol.94 (12), p.1374

2023

Volltextzugriff (PDF)

1 – 25 von 377

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(345)
Mit Volltextzugriff
(235)

Publikationsform

Sprache

Englisch
(236)
Russisch
(162)
Japanisch
(13)
Ukrainisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy "REGATТA" results)

Resumption of anticoagulant therapy after major bleeding and recurrence of hemorrhagic complications in patients with atrial fibrillation with a high risk of stroke and thromboembolism (based on the results of 20 years of observation)

Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions

Chronic Kidney Disease is a Predictor of Recurrent Bleeding in Patients With Atrial Fibrillation After Resuming Anticoagulant Therapy (based on REGistry of Long-term AnTithrombotic TherApy (REGATA-2)

New Possibilities in the Treatment of Patients With Stable Manifestations of Atherothrombosis

To Whom Among Patients Survivors an Acute Coronary Syndrome, Can be Strengthened Two-antiplatelet Therapy With Oral Anticoagulants?

Value of comparative studies of “real clinical practice” in modern cardiology. Position paper based on the expert council discussion dated 12/18/2020

Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage

Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay

Recommendations of the Society of Specialists in Urgent Cardiology Diagnosis and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. Part 1

Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up

Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins

Results of three year observation of outpatients with clinical manifestations of atherothrombosis (analysis of Russian population of REACH registry)

Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications

Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions

Anticoagulant therapy in cardiology: yesterday, today, tomorrow

Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment

Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis

Pharmacogenetics of clopidogrel and its clinical significance

New Possibilities in the Treatment of Patients With Stable Manifestations of Atherothrombosis

HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy

Characteristics and outcomes of atherothrombosis in ambulatory patients in Russian Federation (according to materials of international register REACH)

High plasma D-dimer and von Willebrand factor levels are associated with risk of upper gastrointestinal bleeding in patients with chronic coronary syndromes receiving long-term antiplatelet therapy

Resumption of anticoagulant therapy after major bleeding and the risk of negative events in patients with atrial fibrillation (based on REGistry of Long-term AnTithrombotic TherApy-2 - REGATA)

Suchergebnisse filtern